Global Vaginal Ring Market 2024-2028

The vaginal ring market is forecasted to grow by USD 748.36 mn during 2023-2028, accelerating at a CAGR of 5.78% during the forecast period. The report on the vaginal ring market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the progressive perspective of consumers toward contraceptives, the growing importance of family planning, and non-contraceptive health benefits.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.25%
CAGR	5.78%
Incremental Value	$748.36mn

Technavio's vaginal ring market is segmented as below:

By Distribution Channel

Pharmacies and clinics
Online retail

By End-user

Hospitals
Gynecology clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the high disposable income as one of the prime reasons driving the vaginal ring market growth during the next few years. Also, an increase in innovative marketing strategies and increasing demand for long-acting contraceptives will lead to sizable demand in the market.

The report on the vaginal ring market covers the following areas:

Vaginal ring market sizing
Vaginal ring market forecast
Vaginal ring market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaginal ring market vendors that include AbbVie Inc., Allergan, Bayer AG, Bos Medicare Surgical, EUROGINE SL, Johnson and Johnson, Mayne Pharma Group Ltd., Merck and Co. Inc., Mithra Pharmaceuticals SA, Novo Nordisk AS, Pfizer Inc., Prasco Laboratories, QPharma Inc., Searchlight Pharma Inc., SMB Corp. of India, Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc.. Also, the vaginal ring market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73124

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global vaginal ring market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
4.2 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Pharmacies and clinics - Market size and forecast 2023-2028
Exhibit 34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
6.4 Online retail - Market size and forecast 2023-2028
Exhibit 38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)
Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Gynecology clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 Bayer AG
Exhibit 115: Bayer AG - Overview
Exhibit 116: Bayer AG - Business segments
Exhibit 117: Bayer AG - Key news
Exhibit 118: Bayer AG - Key offerings
Exhibit 119: Bayer AG - Segment focus
12.5 Bos Medicare Surgical
Exhibit 120: Bos Medicare Surgical - Overview
Exhibit 121: Bos Medicare Surgical - Key offerings
12.6 EUROGINE SL
Exhibit 122: EUROGINE SL - Overview
Exhibit 123: EUROGINE SL - Product / Service
Exhibit 124: EUROGINE SL - Key offerings
12.7 Johnson and Johnson
Exhibit 125: Johnson and Johnson - Overview
Exhibit 126: Johnson and Johnson - Business segments
Exhibit 127: Johnson and Johnson - Key news
Exhibit 128: Johnson and Johnson - Key offerings
Exhibit 129: Johnson and Johnson - Segment focus
12.8 Mayne Pharma Group Ltd.
Exhibit 130: Mayne Pharma Group Ltd. - Overview
Exhibit 131: Mayne Pharma Group Ltd. - Business segments
Exhibit 132: Mayne Pharma Group Ltd. - Key news
Exhibit 133: Mayne Pharma Group Ltd. - Key offerings
Exhibit 134: Mayne Pharma Group Ltd. - Segment focus
12.9 Merck and Co. Inc.
Exhibit 135: Merck and Co. Inc. - Overview
Exhibit 136: Merck and Co. Inc. - Business segments
Exhibit 137: Merck and Co. Inc. - Key news
Exhibit 138: Merck and Co. Inc. - Key offerings
Exhibit 139: Merck and Co. Inc. - Segment focus
12.10 Mithra Pharmaceuticals SA
Exhibit 140: Mithra Pharmaceuticals SA - Overview
Exhibit 141: Mithra Pharmaceuticals SA - Product / Service
Exhibit 142: Mithra Pharmaceuticals SA - Key offerings
12.11 Novo Nordisk AS
Exhibit 143: Novo Nordisk AS - Overview
Exhibit 144: Novo Nordisk AS - Business segments
Exhibit 145: Novo Nordisk AS - Key offerings
Exhibit 146: Novo Nordisk AS - Segment focus
12.12 Pfizer Inc.
Exhibit 147: Pfizer Inc. - Overview
Exhibit 148: Pfizer Inc. - Product / Service
Exhibit 149: Pfizer Inc. - Key news
Exhibit 150: Pfizer Inc. - Key offerings
12.13 Prasco Laboratories
Exhibit 151: Prasco Laboratories - Overview
Exhibit 152: Prasco Laboratories - Product / Service
Exhibit 153: Prasco Laboratories - Key offerings
12.14 QPharma Inc.
Exhibit 154: QPharma Inc. - Overview
Exhibit 155: QPharma Inc. - Product / Service
Exhibit 156: QPharma Inc. - Key offerings
12.15 SMB Corp. of India
Exhibit 157: SMB Corp. of India - Overview
Exhibit 158: SMB Corp. of India - Product / Service
Exhibit 159: SMB Corp. of India - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 TherapeuticsMD Inc.
Exhibit 165: TherapeuticsMD Inc. - Overview
Exhibit 166: TherapeuticsMD Inc. - Product / Service
Exhibit 167: TherapeuticsMD Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations